byiShook Opinion
Dec 20, 2024 - 09:40
Vertex stock was floundering even before Thursday when the company's non-opioid pain drug underperformed expectations in a midstage study. The post Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study? appeared first on Investor's Business Daily.
Vertex stock was floundering even before Thursday when the company's non-opioid pain drug underperformed expectations in a midstage study.
The post Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study? appeared first on Investor's Business Daily.